Full Text View
Tabular View
No Study Results Posted
Related Studies
To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1
The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2004 by National Institute on Drug Abuse (NIDA).
Recruitment status was  Active, not recruiting
Study NCT00100074   Information provided by National Institute on Drug Abuse (NIDA)

First Received on December 22, 2004.   Last Updated on October 25, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amphetamine-Related Disorders
More general conditions related to this trial
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Lobeline
More general drug interventions related to this trial
Autonomic Agents
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services